Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Payables: 2009-2024

Historic Payables for Rockwell Medical (RMTI) over the last 16 years, with Dec 2024 value amounting to $3.1 million.

  • Rockwell Medical's Payables fell 35.47% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.3 million, marking a year-over-year decrease of 44.69%. This contributed to the annual value of $3.1 million for FY2024, which is 34.10% down from last year.
  • As of FY2024, Rockwell Medical's Payables stood at $3.1 million, which was down 34.10% from $4.8 million recorded in FY2023.
  • In the past 5 years, Rockwell Medical's Payables registered a high of $4.8 million during FY2023, and its lowest value of $3.1 million during FY2024.
  • Over the past 3 years, Rockwell Medical's median Payables value was $4.6 million (recorded in 2022), while the average stood at $4.2 million.
  • As far as peak fluctuations go, Rockwell Medical's Payables increased by 9.89% in 2020, and later crashed by 34.10% in 2024.
  • Over the past 5 years, Rockwell Medical's Payables (MRY) stood at $4.2 million in 2020, then rose by 0.51% to $4.2 million in 2021, then rose by 9.10% to $4.6 million in 2022, then increased by 4.48% to $4.8 million in 2023, then crashed by 34.10% to $3.1 million in 2024.
  • Its Payables stands at $3.1 million for FY2024, versus $4.8 million for FY2023 and $4.6 million for FY2022.